S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Mistras Group Announces Results for First Quarter FY'15 (2014/10/7)|
|MISTRAS Group Acquires The NACHER Corporation, a Leading Offshore Maintenance & Inspection Services Company (2014/8/28)|
|MISTRAS Group Announces Conference Call to Discuss Fiscal 2015 First Quarter Results on October 8, 2014 (2014/9/23)|
|Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Myasthenia Gravis|
|Lipocine Announces Positive Top-Line Results in Its Phase 3 Study of LPCN 1021 for Oral Testosterone Replacement Therapy|
|Dr. Reddy’s Announces the Launch of Sirolimus Tablets, 1 mg and 2 mg|
|Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets|
|Ipsen Announces Positive Results from Phase III Clinical Study of Decapeptyl® (triptorelin pamoate) 11.25 mg Administered by Subcutaneous Route to Prostate Cancer Patients|
|Lannett Receives FDA Approval for Letrozole Tablets USP 2.5 mg|
|Allergan Announces FDA Approves Revised Indication for OZURDEX® (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema|
Click above to view more mutual fund data and stats for mg - Mistras Group Inc.